Avidity Biosciences stock price

아트리움 테라퓨틱스NASDAQ:RNA · Nasdaq · Healthcare · sector #20
$8.26+4.16%
2026-10-08 close
Loading chart…

Avidity Biosciences's chart data is dated 2026-10-08. Recorded technical signals: RSI rebound, MACD bullish cross, Mean reversion. There are 0 published signal records.

Avidity Biosciences last closed at $8.26 (+4.16%) on 2026-10-08. Signals today: RSI rebound, MACD bullish cross, Mean reversion. Listed on Nasdaq. Trailing 12 months PER is -1.5×. Its overall grade ranks 333 of 738 stocks in Healthcare.

About this company

Avidity Biosciences last closed at $8.26 (+4.16%) on 2026-10-08. Signals today: RSI rebound, MACD bullish cross, Mean reversion. Listed on Nasdaq.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall B · 333/738

Valuation grade B+

Details →

Related stocks

  • AstraZenecaCustomer

    Avidity의 올리고뉴클레오타이드 기반 항체-올리고 접합체(AOC) 플랫폼에 대한 협력/개발 파트너

  • RocheCustomer

    Avidity의 근이영양증 등 희귀질환 파이프라인과 관련된 잠재적 제약 협력·상업화 파트너 후보

  • NovartisCompetitor

    희귀근육질환 및 RNA 치료제 분야에서 경쟁하는 대형 제약사

Details →
About Avidity Biosciences
What technical signals does Avidity Biosciences (RNA) have?
Avidity Biosciences current technical signals: RSI rebound, MACD bullish cross, Mean reversion.
Is Avidity Biosciences a cup-and-handle pattern?
No. Avidity Biosciences has no valid Cup signal right now.
What published figures are available for Avidity Biosciences?
Market cap: $6.21B. Trailing 12 months PER: -1.5×. Latest quarter PBR: 0.66×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Major stocks in the same sector

2026-10-09 dataset

Turn what you saw on this name into a strategy

Ask Q about Avidity Biosciences, or open the plan table on the main site.

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

Avidity Biosciences notifications

Quantus Signal · live data · not investment advice · Privacy Policy